Page 6 - Mark Neumann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vahanian & Associates Financial Planning Inc. reduced its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 5.7% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 15,217 shares of the biopharmaceutical company’s stock after selling 915 shares during the period. Intra-Cellular Therapies makes up […]

Harbor Capital Advisors Inc. bought a new stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 734 shares of the biopharmaceutical company’s stock, valued at approximately $46,000. A number of other hedge […]

DnB Asset Management AS lifted its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 41.0% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 14,273 shares of the biopharmaceutical company’s stock after buying an additional 4,151 shares during […]

AlphaCentric Advisors LLC lifted its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 240.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,500 shares of the biopharmaceutical company’s stock after acquiring an additional 18,000 shares during the quarter. […]

Miramar Capital LLC lifted its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 2.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,550 shares of the biopharmaceutical company’s stock after buying an additional 555 shares during the […]